ATE223209T1 - Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie - Google Patents

Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie

Info

Publication number: ATE223209T1
Authority: AT; Austria
Prior art keywords: cancers; modulators; improve; treatment; propargylamin
Prior art date: 1998-01-13

Application number

AT99900405T

Other languages

English (en)

Inventor

I Alick Paterson

R C Warrington

Alan A Boulton

Original Assignee

Univ Saskatchewan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-13

Filing date

1999-01-13

Publication date

2002-09-15

1999-01-13 Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan

2002-09-15 Application granted granted Critical

2002-09-15 Publication of ATE223209T1 publication Critical patent/ATE223209T1/de

Links

JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 title abstract 3
238000011275 oncology therapy Methods 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 6
239000002246 antineoplastic agent Substances 0.000 abstract 3
229940041181 antineoplastic drug Drugs 0.000 abstract 3
201000011510 cancer Diseases 0.000 abstract 3
238000002512 chemotherapy Methods 0.000 abstract 3
238000011282 treatment Methods 0.000 abstract 2
206010059866 Drug resistance Diseases 0.000 abstract 1
208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 abstract 1
206010070863 Toxicity to various agents Diseases 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1
230000001988 toxicity Effects 0.000 abstract 1
231100000419 toxicity Toxicity 0.000 abstract 1
238000011269 treatment regimen Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT99900405T 1998-01-13 1999-01-13 Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie ATE223209T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7102398P	1998-01-13	1998-01-13
PCT/CA1999/000005 WO1999036076A1 (en)	1998-01-13	1999-01-13	Composition containing propargylamine for enhancing cancer therapy

Publications (1)

Publication Number	Publication Date
ATE223209T1 true ATE223209T1 (de)	2002-09-15

Family

ID=22098802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99900405T ATE223209T1 (de)	1998-01-13	1999-01-13	Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie

Country Status (7)

Country	Link
EP (1)	EP1049478B1 (de)
JP (1)	JP2004519409A (de)
AT (1)	ATE223209T1 (de)
AU (1)	AU1956399A (de)
CA (1)	CA2318693A1 (de)
DE (1)	DE69902748T2 (de)
WO (1)	WO1999036076A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6033682A (en)	1995-01-13	2000-03-07	Somerset Pharmaceuticals, Inc.	S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
AU8679801A (en) *	2000-08-28	2002-03-22	Somerset Pharmaceuticals Inc	Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
AU2006320327A1 (en) *	2005-12-01	2007-06-07	Duke University	Compounds and methods for inhibiting apoptosis
EP2776020B1 (de) *	2011-11-09	2019-09-11	Teikoku Seiyaku Co., Ltd.	Verfahren zur behandlung von neoplasmen der haut
WO2016088111A1 (en) *	2014-12-05	2016-06-09	Semmelweis University	Arylalkylamine compounds for use in the prevention or treatment of cancer
HUP1900281A1 (hu) *	2019-08-06	2021-03-01	Toxie Europe Intelligens Kemiai Szenzorokat Kutato	Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460599A (en) *	1979-12-05	1984-07-17	University Patents, Inc.	Mitomycin analogs
US5169868A (en) *	1991-03-01	1992-12-08	University Of Saskatchewan	Aliphatic propargylamines as specific mao-b inhibitors

1999
- 1999-01-13 AT AT99900405T patent/ATE223209T1/de not_active IP Right Cessation
- 1999-01-13 DE DE69902748T patent/DE69902748T2/de not_active Expired - Fee Related
- 1999-01-13 AU AU19563/99A patent/AU1956399A/en not_active Abandoned
- 1999-01-13 JP JP2000539849A patent/JP2004519409A/ja active Pending
- 1999-01-13 CA CA002318693A patent/CA2318693A1/en not_active Abandoned
- 1999-01-13 WO PCT/CA1999/000005 patent/WO1999036076A1/en not_active Ceased
- 1999-01-13 EP EP99900405A patent/EP1049478B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2004519409A (ja)	2004-07-02
DE69902748D1 (de)	2002-10-10
AU1956399A (en)	1999-08-02
CA2318693A1 (en)	1999-07-22
WO1999036076A1 (en)	1999-07-22
HK1032204A1 (en)	2001-07-13
DE69902748T2 (de)	2003-08-07
EP1049478A1 (de)	2000-11-08
EP1049478B1 (de)	2002-09-04

Similar Documents

Publication	Publication Date	Title
YU176191A (sh)	1994-01-20	Derivati hinazolina za pojačavanje antitumorne aktivnosti
TR200102005T2 (tr)	2001-12-21	Poli(adp-ribaz) polimerazların trisiklik inhibitörleri.
BR9909393A (pt)	2000-12-26	Agente antitumor, uso de um derivado de estilbeno e um composto de coordenação de platina, e, processo para o tratamento ou melhoramento de um tumor
EA200000087A1 (ru)	2000-08-28	Повышение эффективности терапии гиперпролиферативных состояний с помощью антиоксиданта
SE9301951D0 (sv)	1993-06-08	Methods for administration of taxol
TR200909479T2 (tr)	2012-02-21	Sinerjistik kombinasyon.
HUP0004262A1 (hu)	2001-08-28	Rákellenes vegyületek
NO983669L (no)	1998-09-23	Coralyne analoger som topoisomeraseinhibitorer
EP2020237A3 (de)	2009-02-11	Ceramidmittel und Chemotherapeutika zur Herbeiführung des Zelltodes
BR0207316A (pt)	2004-02-10	Derivados de epotilona para o tratamento de tumores refratários
EP0211354A3 (de)	1988-02-10	Nukleoside und ihre Verwendung als antineoplastische Wirkstoffe
AR023616A1 (es)	2002-09-04	Preparaciones combinadas que comprenden derivados de antraciclina
BR0213424A (pt)	2004-12-14	Uso aperfeiçoado de composto antitumoral na terapia contra câncer
DE69902748D1 (de)	2002-10-10	Propargylamin enthaltende zusammensetzung zur verbesserung der krebstherapie
PT1085884E (pt)	2005-07-29	Combinacao de compostos seleniferos com gemcitabina ou mitomicina c
ATE278422T1 (de)	2004-10-15	Ascomycin enthaltende topische zubereitungen
EP0974363A4 (de)	2003-05-07	Heilmittel für die drogenabhängigkeit
IL121272A (en)	2000-06-01	Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
NO983177L (no)	1998-07-10	Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
NO941915L (no)	1994-11-28	Madikament for nervebeskyttelse
MX9203361A (es)	1992-07-01	Composiciones farmaceuticas que contienen cloruro de galio.
NO970178L (no)	1997-01-15	Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
KR960700734A (ko)	1996-02-24	사람 암에 대한 시스플래틴/타목시펜 배합 치료(Combination cisplatin/tamoxifen therapy for human cancers)
KR927002224A (ko)	1992-09-03	항종양효과증강제 및 항종양제
WO2003020223A3 (en)	2003-06-26	A cancer treatment system

Legal Events

Date	Code	Title	Description
2003-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties